New diethylsilylacetylenic linker for parallel solid-phase synthesis of libraries of hydroxy acetylenic steroid derivatives with improved metabolic stability

ACS Combinatorial Science

Volumn 14, Issue 6, 2012, Pages 347-351

  Talbot, Amélie ^a   Maltais, René ^a   Poirier, Donald ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

hydroxy acetylenic compounds; library; linker; solid phase synthesis; steroids

Indexed keywords

ALKYNE; STEROID;

ARTICLE; CHEMISTRY; METHODOLOGY; MOLECULAR LIBRARY; SOLID PHASE SYNTHESIS; SYNTHESIS;

ALKYNES; SMALL MOLECULE LIBRARIES; SOLID-PHASE SYNTHESIS TECHNIQUES; STEROIDS;

EID: 84862155403     PISSN: 21568952     EISSN: None     Source Type: Journal    
DOI: 10.1021/co300034y     Document Type: Article

References (22)

1. Moshet, C.; Hollender, J. Microbial degradation of steroid hormones in the environment and technical systems. Term Paper, Swiss Federal Institude of Technology, Institute of Biogeochemistry and Polluant Dynamics (IBP-ETH), Universitaetsstrasse 16, CH-8092 Zurich, 2009.
2. Kuhl, H. Pharmacology of estrogens and progestogens: influence of different routes of administration Climateric 2005, 8 (Suppl 1) 3-63
3. De Mes, T. Z. D. Fate of estrogens in biological treatment of concentrated black water. PhD-Thesis Wageningen University, Wageningen, The Netherlands, 2007.
4. Ebner, T.; Remmel, R. P.; Burchell, B. Human bilirubin UDP-glucuronosyltransferase catalyses the glucuronidation of ethinylestradiol Mol. Pharmacol. 1993, 43, 649-654
5. de Wildt, S. N.; Kearns, G. L.; Leeder, J. S.; van der Anker, J. N. Glucuronidation in humans-Pharmacogenetic and developmental aspects Clin. Pharmacokinet. 1999, 36, 439-452
6. Huber, M. M.; Ternes, T. A.; Von Gunten, U. Removal of estrogenic activity and formation of oxidation products during ozonation of 17α-ethinylestradiol Environ. Sci. Technol. 2004, 38, 5177-5186
7. Thorpe, K. L.; Cummings, R. I.; Hutchinson, T. H.; Scholze, M.; Brighty, G.; Sumpter, J. P.; Tyler, C. R. Relative potencies and combination effects of steroidal estrogens in fish Environ. Sci. Technol. 2003, 37, 1142-1149
8. O'Grady, D. Biodegradation of 17α-ethinylestradiol in wastewater. PhD-Thesis McGill University, Montréal, 2007.
9. Williams, C. L.; Stancel, G. M. Estrogens and progestins. In The Pharmacological Basis of Therapeutics, 9 th ed.; Gilman, A. G.; Goodman, L. S.; Hardman, G.; Limbird, L., Eds.; McGraw-Hill,: New York, 1996; 1411-1440.
10. Frincke, J. M.; Reading, C.; Auci, D.; Ahlem, C. N. Preparation of androstenes and androstanes for treating autoimmune conditions and related diseases. U.S. Patent 20080153792, Jun 26, 2008.
11. Flores-Riveros, J.; Frincke, J. M.; Reading, C.; Stickney, D.; Ahlem, C. N. Drug screening and treatment methods. U.S. Patent 20080146532, Jun 19, 2008.
12. Poirier, D.; Roy, J.; Maltais, R. Preparation of 2-(N -substituted pirerazinyl) steroid derivatives as anticancer agents. International Patent Application WO 2010060215, June 3, 2010; U.S. Patent Application 2011/0312926 A1, Université Laval, Qc, 121 pp.
13. Al-Nadaf, A. H.; Taha, M. O. Discovery of new rennin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluation J. Mol. Graph. Model. 2011, 29, 843-864
14. Burden, P. M.; Ai, T. H.; Lin, H. Q.; Akinci, M.; Costandi, M.; Hambley, T. M.; Johnston, G. A. R. Chiral derivatives of 2-cyclohexylideneperhydro-4,7- methanoindenes, a novel class of nonsteroidal androgen receptor gigan: synthesis, X-ray analysis and biological activity J. Med. Chem. 2000, 43, 4629-4635
15. Adema, A. D.; Bijnsdorp, I. V.; Sandvold, M. L.; Verheul, H. M.; Peters, G. J. Innovations and opportinities to improve conventional (deoxy)nucleoside and fluoropyrimidine analogs in cancer Curr. Med. Chem. 2009, 16, 4632-4643
16. Bijnsdorp, I. V.; Schwendener, R. A.; Schott, H.; Fichtner, I.; Smid, K.; Laan, A. C.; Schott, S.; Losekoot, N.; Honeywell, R. J.; Peters, G. J. Cellular pharmacology of multi- and duplex drugs consisting of ethinylcytidine and 5-fluoro-2′-deoxyuridine Invest. New Drug. 2011, 29, 248-257
17. Galmarini, C. M.; Popowycz, F.; Joseph, B. Cytotoxic nucleoside analogues: differents strategies to improve their clinical efficacy Curr. Med. Chem. 2008, 15, 1072-1082
18. Kloosterboer, H. J.; Reed, M. J. Tibolone: a selective tissue estrogenic activity regulator (STEAR) Maturitas 2004, 48 (Suppl. 1) S1-S42
19. Francis, C. L.; Williamson, N. M.; Ward, D. A. The synthesis of tetrahydroquinolines related to virantmycin Synthesis 2004, 16, 2685-2691
20. Wuts, P. G. M.; Ritter, A. R. A novel synthesis of spironolactone. An application of the hydroformylation reaction J. Org. Chem. 1989, 54, 5180-5182
21. Roy, J.; DeRoy, P.; Poirier, D. 2β-(N -Substituted piperazino)-5α-androstane-3α,17β-diols: parallel solid-phase synthesis and antiproliferative activity on human leukemia HL-60 Cells J. Comb. Chem. 2007, 9, 347-358
22. Roy, J.; Maltais, R.; Jegham, H.; Poirier, D. Libraries of 2β-(N -Substituted piperazino)-5α-androstane-3α,17β-diols: chemical synthesis and cytotoxic effects on human leukemia HL-60 cells and on normal lymphocytes Mol. Diversity 2011, 15, 317-339